Is There an Increased Risk of Lymphoma and Malignancies Under Anti- TNF Therapy in IBD?
Journal:
Current Drug Targets
Volume:
11
Page:
179-186
Author(s):
P. L. Lakatos and P. Miheller
Low Grade Inflammation as a Common Pathogenetic Denominator in Age-Related Diseases: Novel Drug Targets for Anti-Ageing Strategies and Successful Ageing Achievement
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
584-596
Author(s):
G. Candore, C. Caruso, E. Jirillo, T. Magrone and S. Vasto
Lipoxygenase Inhibitors for Cancer Prevention: Promises and Risks
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
725-733
Author(s):
Cecilia Menna, Fabiola Olivieri, Alfonso Catalano and Antonio Procopio
Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver Disease: From a Clinical to a Molecular Association
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
741-752
Author(s):
S. Petta and A. Craxi
Evaluation of Drug Transporter Interactions in Drug Discovery and Development
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
13
Page:
112-134
Author(s):
Yurong Lai, Kathleen E. Sampson and Jeffrey C. Stevens
Application of In Vivo Animal Models to Characterize the Pharmacokinetic and Pharmacodynamic Properties of Drug Candidates in Discovery Settings
Journal:
Combinatorial Chemistry & High Throughput Screening
Volume:
13
Page:
207-218
Author(s):
Benny M. Amore, John P. Gibbs and Maurice G. Emery
IP6 in Cancer Therapy: Past, Present and Future
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
1-12
Author(s):
Agata Matejuk and Abulkalam Shamsuddin
Liver-Directed Regional Therapy in the Multi-Disciplinary Management of Hepatocellular Cancer
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
19-25
Author(s):
Maheswari Senthil, Brian Mailey, Lucille Leong, Vincent Chung, Yun Yen, Yi-Jen Chen, Howard Marx and Joseph Kim
Regulatory T Cells and Cancer Therapy: An Old Story with a New Hope
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
34-40
Author(s):
Xinhai Zhang, Rick F. Thorne, Thomas E. Wagner and Yanzhang Wei
MicroRNA-21 as a Novel Therapeutic Target
Journal:
Current Cancer Therapy Reviews
Volume:
6
Page:
41-50
Author(s):
Mohit Sachdeva, Shoumin Zhu and Yin-Yuan Mo